Detsika Maria G, Lianos Elias A
First Department of Critical Care Medicine & Pulmonary Services, GP Livanos and M. Simou Laboratories, National & Kapodistrian University of Athens, Medical School, Evangelismos Hospital, 10675 Athens, Greece.
Thorax Foundation, Research Center of Intensive Care and Emergency Thoracic Medicine, 10675 Athens, Greece.
Antioxidants (Basel). 2021 Jan 6;10(1):60. doi: 10.3390/antiox10010060.
Heme oxygenase is a cytoprotective enzyme with strong antioxidant and anti-apoptotic properties. Its cytoprotective role is mainly attributed to its enzymatic activity, which involves the degradation of heme to biliverdin with simultaneous release of carbon monoxide (CO). Recent studies uncovered a new cytoprotective role for heme oxygenase-1 (HO-1) by identifying a regulatory role on the complement control protein decay-accelerating factor. This is a key complement regulatory protein preventing dysregulation or overactivation of complement cascades that can cause kidney injury. Cell-specific targeting of HO-1 induction may, therefore, be a novel approach to attenuate complement-dependent forms of kidney disease.
血红素加氧酶是一种具有强大抗氧化和抗凋亡特性的细胞保护酶。其细胞保护作用主要归因于其酶活性,该活性涉及将血红素降解为胆绿素并同时释放一氧化碳(CO)。最近的研究通过确定血红素加氧酶-1(HO-1)对补体控制蛋白衰变加速因子的调节作用,揭示了其新的细胞保护作用。这是一种关键的补体调节蛋白,可防止补体级联反应的失调或过度激活,而补体级联反应失调或过度激活会导致肾损伤。因此,细胞特异性诱导HO-1可能是减轻补体依赖性肾病形式的一种新方法。